ReviewExperimental hematology & oncology2022

Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information.

Ryuji Hamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.